• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对患有糖尿病肾病的非裔美国人延缓早期慢性肾病的生活方式干预:前后对照试点研究。

A Lifestyle Intervention to Delay Early Chronic Kidney Disease in African Americans With Diabetic Kidney Disease: Pre-Post Pilot Study.

作者信息

Ozieh Mukoso N, Egede Leonard E

机构信息

Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI, United States.

出版信息

JMIR Form Res. 2022 Mar 15;6(3):e34029. doi: 10.2196/34029.

DOI:10.2196/34029
PMID:35289751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8965678/
Abstract

BACKGROUND

Behavioral factors, such as lifestyle, have been shown to explain approximately 24% of the excess risk of chronic kidney disease (CKD) among African Americans. However, there are limited intervention studies culturally tailored to African Americans with type 2 diabetes mellitus and CKD.

OBJECTIVE

The main objective of this study was to examine the feasibility and preliminary efficacy of a culturally tailored lifestyle intervention among African Americans with type 2 diabetes mellitus and CKD.

METHODS

A pre-post design was used to test the feasibility of a lifestyle intervention in 30 African American adults recruited from the Medical University of South Carolina between January 2017 and February 2017. A research nurse delivered the manualized study intervention weekly for 6 weeks. Clinical outcomes (hemoglobin A, blood pressure, and estimated glomerular filtration rate [eGFR]) were measured at baseline and postintervention. Disease knowledge, self-care, and behavior outcomes were also measured using validated structured questionnaires at baseline and postintervention. Descriptive statistics and effect sizes were calculated to determine clinically important changes from baseline.

RESULTS

Significant pre-post mean differences and decreases were observed for hemoglobin A (mean 0.75%, 95% CI 0.16-1.34; P=.01), total cholesterol (mean 16.38 mg/dL, 95% CI 5.82-26.94; P=.004), low-density lipoprotein (mean 13.73 mg/dL, 95% CI 3.91-23.54; P=.008), and eGFR (mean 6.73 mL/min/1.73m, 95% CI 0.97-12.48; P=.02). Significant pre-post mean differences and increases were observed for CKD self-efficacy (mean -11.15, 95% CI -21.55 to -0.75; P=.03), CKD knowledge (mean -2.62, 95% CI -3.98 to -1.25; P<.001), exercise behavior (mean -1.21, 95% CI -1.96 to -0.46; P=.003), and blood sugar testing (mean -2.15, 95% CI -3.47 to -0.83; P=.003).

CONCLUSIONS

This study provides preliminary data for a large-scale appropriately powered randomized controlled trial to examine a culturally tailored lifestyle intervention in African Americans with type 2 diabetes mellitus and CKD in order to improve clinical, knowledge, self-care, and behavior outcomes in this population.

摘要

背景

行为因素,如生活方式,已被证明可解释非裔美国人慢性肾脏病(CKD)额外风险的约24%。然而,针对患有2型糖尿病和CKD的非裔美国人进行文化定制干预的研究有限。

目的

本研究的主要目的是检验针对患有2型糖尿病和CKD的非裔美国人进行文化定制生活方式干预的可行性和初步疗效。

方法

采用前后设计,测试2017年1月至2017年2月从南卡罗来纳医科大学招募的30名非裔美国成年人生活方式干预的可行性。一名研究护士每周进行一次手册化研究干预,为期6周。在基线和干预后测量临床结局(糖化血红蛋白、血压和估计肾小球滤过率[eGFR])。还在基线和干预后使用经过验证的结构化问卷测量疾病知识、自我护理和行为结局。计算描述性统计量和效应大小,以确定与基线相比具有临床意义的变化。

结果

糖化血红蛋白(平均0.75%,95%CI 0.16 - 1.34;P = 0.01)、总胆固醇(平均16.38mg/dL,95%CI 5.82 - 26.94;P = 0.004)、低密度脂蛋白(平均13.73mg/dL,95%CI 3.91 - 23.54;P = 0.008)和eGFR(平均6.73mL/min/1.73m²,95%CI 0.97 - 12.48;P = 0.02)观察到显著的前后平均差异及降低。CKD自我效能感(平均 - 11.15,95%CI - 21.55至 - 0.75;P = 0.03)、CKD知识(平均 - 2.62,95%CI - 3.98至 - 1.25;P < 0.001)、运动行为(平均 - 1.21,95%CI - 1.96至 - 0.46;P = 0.003)和血糖检测(平均 - 2.15,95%CI - 3.47至 - 0.83;P = 0.003)观察到显著的前后平均差异及增加。

结论

本研究为大规模、有足够效力的随机对照试验提供了初步数据,以检验针对患有2型糖尿病和CKD的非裔美国人进行文化定制生活方式干预,从而改善该人群的临床、知识、自我护理和行为结局。

相似文献

1
A Lifestyle Intervention to Delay Early Chronic Kidney Disease in African Americans With Diabetic Kidney Disease: Pre-Post Pilot Study.一项针对患有糖尿病肾病的非裔美国人延缓早期慢性肾病的生活方式干预:前后对照试点研究。
JMIR Form Res. 2022 Mar 15;6(3):e34029. doi: 10.2196/34029.
2
A Culturally Tailored Diabetes Self-Management Intervention Incorporating Race-Congruent Peer Support to Address Beliefs, Medication Adherence and Diabetes Control in African Americans: A Pilot Feasibility Study.一项针对非裔美国人的、融入种族一致的同伴支持以解决信念、药物依从性和糖尿病控制问题的文化定制糖尿病自我管理干预措施:一项试点可行性研究。
Patient Prefer Adherence. 2022 Oct 25;16:2893-2912. doi: 10.2147/PPA.S384974. eCollection 2022.
3
A feasibility pilot trial of a peer-support educational behavioral intervention to improve diabetes medication adherence in African Americans.一项关于同伴支持教育行为干预以提高非裔美国人糖尿病药物依从性的可行性试点试验。
Pilot Feasibility Stud. 2022 Nov 14;8(1):240. doi: 10.1186/s40814-022-01198-7.
4
Chronic kidney disease in Russia: the Ural eye and medical study.俄罗斯的慢性肾脏病:乌拉尔之眼与医学研究。
BMC Nephrol. 2020 May 25;21(1):198. doi: 10.1186/s12882-020-01843-4.
5
Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study.人群归因分数:2 型糖尿病患者的可改变生活方式因素对慢性肾脏病和死亡率的影响:一项队列研究。
Am J Kidney Dis. 2016 Jul;68(1):29-40. doi: 10.1053/j.ajkd.2015.12.019. Epub 2016 Jan 30.
6
Combined diabetes-renal multifactorial intervention in patients with advanced diabetic nephropathy: Proof-of-concept.晚期糖尿病肾病患者的糖尿病 - 肾脏联合多因素干预:概念验证
J Diabetes Complications. 2017 Mar;31(3):624-630. doi: 10.1016/j.jdiacomp.2016.11.019. Epub 2016 Dec 8.
7
Combined Diabetes Education/Skills Training and Social Needs Resolution Intervention for Older African Americans with Poorly Controlled Type 2 Diabetes (DM Social Needs): Study Protocol for a Randomized Controlled Trial.针对2型糖尿病控制不佳的老年非裔美国人的糖尿病教育/技能培训与社会需求解决联合干预(糖尿病社会需求):一项随机对照试验的研究方案
Healthcare (Basel). 2024 Oct 6;12(19):1991. doi: 10.3390/healthcare12191991.
8
A Behavioral Lifestyle Intervention Enhanced With Multiple-Behavior Self-Monitoring Using Mobile and Connected Tools for Underserved Individuals With Type 2 Diabetes and Comorbid Overweight or Obesity: Pilot Comparative Effectiveness Trial.一项针对患有2型糖尿病合并超重或肥胖的弱势群体,采用移动和联网工具进行多行为自我监测强化的行为生活方式干预:试点比较有效性试验
JMIR Mhealth Uhealth. 2018 Apr 10;6(4):e92. doi: 10.2196/mhealth.4478.
9
Development and Efficacy of an Electronic, Culturally Adapted Lifestyle Counseling Tool for Improving Diabetes-Related Dietary Knowledge: Randomized Controlled Trial Among Ethnic Minority Adults With Type 2 Diabetes Mellitus.一种经文化调适的电子生活方式咨询工具对改善糖尿病相关饮食知识的开发与效果:2型糖尿病成年少数民族患者的随机对照试验
J Med Internet Res. 2019 Oct 16;21(10):e13674. doi: 10.2196/13674.
10
A Self-management Approach for Dietary Sodium Restriction in Patients With CKD: A Randomized Controlled Trial.一种针对慢性肾脏病患者饮食钠限制的自我管理方法:一项随机对照试验。
Am J Kidney Dis. 2020 Jun;75(6):847-856. doi: 10.1053/j.ajkd.2019.10.012. Epub 2020 Jan 16.

引用本文的文献

1
Components in downstream health promotions to reduce sugar intake among adults: a systematic review.下游健康促进措施中的成分,以减少成年人的糖摄入量:系统评价。
Nutr J. 2024 Jan 17;23(1):11. doi: 10.1186/s12937-023-00884-3.
2
Combination of Risks of BMI and Health-Related Lifestyles on Kidney Function in the Prediabetic Japanese Population: A Prospective Cohort Study.BMI 与健康相关生活方式联合对日本糖尿病前期人群肾功能的影响:一项前瞻性队列研究。
Int J Environ Res Public Health. 2023 Mar 30;20(7):5338. doi: 10.3390/ijerph20075338.

本文引用的文献

1
Stigma as a Barrier to Participant Recruitment of Minority Populations in Diabetes Research: Development of a Community-Centered Recruitment Approach.耻辱感作为糖尿病研究中少数族裔人群参与招募的障碍:以社区为中心的招募方法的发展。
JMIR Diabetes. 2021 May 3;6(2):e26965. doi: 10.2196/26965.
2
Structural Racism, Social Risk Factors, and Covid-19 - A Dangerous Convergence for Black Americans.结构性种族主义、社会风险因素与新冠疫情——美国黑人面临的危险交集
N Engl J Med. 2020 Sep 17;383(12):e77. doi: 10.1056/NEJMp2023616. Epub 2020 Jul 22.
3
A population health dietary intervention for African American adults with chronic kidney disease: The Fruit and Veggies for Kidney Health randomized study.
一项针对患有慢性肾病的非裔美国成年人的人群健康饮食干预:“肾脏健康的水果和蔬菜”随机研究。
Contemp Clin Trials Commun. 2020 Feb 4;17:100540. doi: 10.1016/j.conctc.2020.100540. eCollection 2020 Mar.
4
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
5
11. Microvascular Complications and Foot Care: .11. 微血管并发症与足部护理:
Diabetes Care. 2020 Jan;43(Suppl 1):S135-S151. doi: 10.2337/dc20-S011.
6
Lifestyle behaviour change for preventing the progression of chronic kidney disease: a systematic review.生活方式行为改变预防慢性肾脏病进展:系统评价。
BMJ Open. 2019 Oct 28;9(10):e031625. doi: 10.1136/bmjopen-2019-031625.
7
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2018年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.
8
Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016: An Analysis of the Global Burden of Disease Study.2002 年至 2016 年美国慢性肾脏病负担变化:全球疾病负担研究分析。
JAMA Netw Open. 2018 Nov 2;1(7):e184412. doi: 10.1001/jamanetworkopen.2018.4412.
9
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.SGLT2 抑制剂用于 2 型糖尿病的心血管和肾脏结局的一级和二级预防:心血管结局试验的系统评价和荟萃分析。
Lancet. 2019 Jan 5;393(10166):31-39. doi: 10.1016/S0140-6736(18)32590-X. Epub 2018 Nov 10.
10
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.达格列净与 2 型糖尿病患者的心血管结局
N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.